The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis
Abstract Cancer-related anorexia/cachexia syndrome (CACS) is characterized by anorexia and loss of body weight. Evidence is insufficient to strongly endorse any pharmacologic agent for the treatment of CACS. In this systematic review, we assessed the efficacy of oral anamorelin treatment for patient...
Main Authors: | Jumpei Taniguchi, Sunao Mikura, Katharina da Silva Lopes |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-42446-x |
Similar Items
-
Anamorelin hydrochloride in the treatment of cancer anorexia–cachexia syndrome: design, development, and potential place in therapy
by: Graf SA, et al.
Published: (2017-08-01) -
Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study
by: Koichi Takayama, et al.
Published: (2023-02-01) -
A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
by: Ivy O. Poon, et al.
Published: (2024-02-01) -
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
by: Claudia Cabeza, et al.
Published: (2018-12-01) -
A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia
by: Yu Liang Lim, et al.
Published: (2022-06-01)